CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues	$ 2,928.5	$ 2,831.3	$ 8,601.4	$ 8,545.9
Cost of Revenue	2,111.2	2,041.4	6,169.6	6,141.9
Gross Profit	817.3	789.9	2,431.8	2,404.0
Selling, general and administrative expenses	401.5	381.8	1,210.6	1,174.0
Amortization of intangibles and other assets	61.7	54.7	179.0	175.5
Net restructuring and other special charges	14.2	10.0	48.4	36.5
Operating Income (Loss)	339.9	343.4	993.8	1,018.0
Other income (expenses):
Interest expense	(60.5)	(59.4)	(176.3)	(186.0)
Equity method income, net	2.4	3.0	7.9	8.5
Investment income	2.9	2.8	4.8	4.2
Other, net	2.7	209.8	(18.2)	209.1
Earnings before income taxes	287.4	499.6	812.0	1,053.8
Provision for income taxes	66.4	180.6	214.4	328.1
Net earnings	221.0	319.0	597.6	725.7
Less: Net earnings attributable to the noncontrolling interest	(0.3)	(0.2)	(0.9)	0.1
Net earnings attributable to Laboratory Corporation of America Holdings	$ 220.7	$ 318.8	$ 596.7	$ 725.8
Basic earnings per common share (in dollars per share)	$ 2.26	$ 3.14	$ 6.08	$ 7.13
Diluted earnings per common share (in dollars per share)	$ 2.25	$ 3.10	$ 6.04	$ 7.04